» Authors » Asami Kondo

Asami Kondo

Explore the profile of Asami Kondo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 861
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, et al.
Nat Med . 2015 Apr; 21(5):457-66. PMID: 25849135
A common key regulator of oncogenic signaling pathways in multiple tumor types is the unique isomerase Pin1. However, available Pin1 inhibitors lack the required specificity and potency for inhibiting Pin1...
12.
Chen C, Li W, Sultana R, You M, Kondo A, Shahpasand K, et al.
Neurobiol Dis . 2015 Jan; 76:13-23. PMID: 25576397
The unique proline isomerase Pin1 is pivotal for protecting against age-dependent neurodegeneration in Alzheimer's disease (AD), with its inhibition providing a molecular link between tangle and plaque pathologies. Pin1 is...
13.
Yoshizaki S, Nishi M, Kondo A, Kojima Y, Yamamoto N, Ryo A
Front Microbiol . 2011 Jun; 2:27. PMID: 21687419
Induced pluripotent stem cells (iPSCs) are artificially derived from somatic cells that have been transduced with defined reprogramming factors. A previous report has indicated the possibility of using iPSCs as...
14.
Nishi M, Akutsu H, Masui S, Kondo A, Nagashima Y, Kimura H, et al.
J Biol Chem . 2011 Feb; 286(13):11593-603. PMID: 21296877
The prominent characteristics of pluripotent stem cells are their unique capacity to self-renew and pluripotency. Although pluripotent stem cell proliferation is maintained by specific intracellular phosphorylation signaling events, it has...
15.
Shimada M, Yoshizaki S, Jounai N, Kondo A, Ichino M, Ryo A, et al.
Vaccine . 2010 Jun; 28(31):4920-7. PMID: 20566393
In this study, we explored the possibility of augmenting human immunodeficiency virus (HIV) gp120-specific cell-mediated immune responses in mice by means of a DNA vaccine encoding a mouse Ig Fcgamma2a...
16.
Yashima S, Yoshizaki S, Shinoda K, Yoshida A, Kondo A, Mizuguchi H, et al.
Vaccine . 2010 Mar; 28(18):3257-64. PMID: 20188679
In this study, we explored immune responses after intramuscular co-administration of the HIV-1 gp160 Env gene-expressing adenovirus (Ad) vector and modified vaccinia virus Ankara (MVA) vector in a mouse model....
17.
Abe S, Okuda K, Ura T, Kondo A, Yoshida A, Yoshizaki S, et al.
J Gene Med . 2009 Apr; 11(7):570-9. PMID: 19391169
Background: Adenovirus type 5 (Ad5) is widely used as a vehicle for vaccine delivery in the treatment of infectious disease and cancer. However, the efficacy of Ad5 vectors has been...
18.
Tashiro K, Kondo A, Kawabata K, Sakurai H, Sakurai F, Yamanishi K, et al.
Biochem Biophys Res Commun . 2008 Dec; 379(1):127-32. PMID: 19103162
Bone marrow stromal cells (BMSCs) are expected to be a source for tissue regeneration because they can differentiate into multiple cell types. Establishment of efficient gene transfer systems for BMSCs...
19.
Kondo A, Sakaguchi M, Makino E, Namba M, Okada S, Huh N
Acta Med Okayama . 2002 Mar; 56(1):31-4. PMID: 11873942
Using 2-dimensional gel electrophoresis, we previously demonstrated that the S100C protein remarkably decreased after immortalization of normal human fibroblasts, and that this protein caused growth inhibition of human tumor cells...